Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmos Corp.

www.pharmoscorp.com

Latest From Pharmos Corp.

NOSTRA nostrum makes vasopharm seek partner for PhIIa brain trauma drug

German firm, vasopharm, said it is seeking a strategic partner to accelerate the further development of VAS203 for traumatic brain injury (TBI), after reporting that Phase IIa results for the drug candidate had 'exceeded expectations'.

Orthopedics Inflammation

Pharmos seeks gout bandwagon partner in last-chance saloon

The Iselin, New Jersey firm Pharmos is touting positive data from a proof-of-concept trial of its last remaining pipeline product in the hope of cashing in on the gout goldrush before its own purse is empty. The company has developed levotofisopam, an S-enantiomer of the benzodiazepine tofisopam, for the treatment of gout, and is hoping that a partner will step forward for the drug.

Orthopedics Spain

Salix to file antibiotic Xifaxan for IBS after Phase III success

Salix Pharmaceuticals' broad spectrum antibiotic Xifaxan (rifaximin) met its primary endpoint in two Phase III trials, providing symptomatic relief from non-constipation irritable bowel syndrome (IBS). The company's share price soared by 51% to close at $20.22 on September 14th on Nasdaq following the news.

Gastrointestinal Infectious Diseases

Czech court upholds antimonopoly body's decision on pharma distributors

A court in Brno, in the south-east of the Czech Republic, has upheld a ruling of the country's office for the protection of competition (UOHS) regarding the country's four largest pharmaceutical distributors interrupting drug supplies to hospitals almost three years ago.

Czech Republic Regulation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pharmos Corp.
  • Senior Management
  • Colin Neill, Pres., CFO, Sec'y & Treasurer
  • Contact Info
  • Pharmos Corp.
    Phone: (732) 452-9556
    99 Wood Ave. S
    Ste. 311
    Iselin, NJ 08830
    USA
UsernamePublicRestriction

Register